Biotech

All Articles

Metsera teams up with Amneal to latch down GLP-1 source

.Along with early stage 1 information today out in the wild, metabolic illness ensemble Metsera is a...

Rivus articles data to back up muscle-sparing being overweight medication insurance claims

.Rivus Pharmaceuticals has revealed the records responsible for its stage 2 excessive weight succeed...

BMS pays out $110M to develop T-cell therapy pact, aiding Best get opportunity to advance prioritized pipe

.Bristol Myers Squibb is paying for Best Medicine $110 thousand ahead of time to cultivate reagents ...

Generate increases another $1B-plus Significant Pharma alliance

.Novartis has actually printer inked a package possibly worth more than $1 billion with Flagship-fou...

Metsera GLP-1 information cut exposes 7.5% fat loss at 36 times

.Recently debuted Metsera is actually unfolding some phase 1 data for its GLP-1 receptor agonist, sh...

Flagship hopes biotechs group to Mirai to enhance genetic medications

.In the middle of the genetic medications arms race, Main Pioneering is revealing a brand-new provid...

BioAge eyes $180M coming from IPO, exclusive placement for excessive weight tests

.BioAge Labs is considering all around $180 million in preliminary profits from an IPO as well as an...

Merck's LAG-3 combo fails intestines cancer stage 3 research

.A try through Merck &amp Co. to uncover the microsatellite stable (MSS) metastatic intestines cance...

Spanish VC finalizes $200M lifestyle sciences fund

.Spain-based Asabys Partners has finalized a fund of 180 thousand euros ($ 200 million), money that ...

BioAge introduces $198M coming from IPO as weight problems biotech participates in Nasdaq

.BioAge Labs is producing just about $200 thousand via its own Nasdaq IPO today, with the profits se...